We’re staring down the barrel of another Trump presidential term, and this time around, the president-elect isn’t wasting any ...

ROACH: I would like to know your opinion on the hepatitis B vaccine and its pros and cons. I'm a 39-year-old man who is thinking about potentially getting one. -- Anon. ANSWER: Hepatitis B is a viral ...

Though they may seem like something from the future, these five cancer vaccines are available now. Here are details about who ...

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Dynavax (DVAX – Research Report). The associated price target ...

Hexavalent, six-in-one vaccine can reduce spread of the disease and cut costs ANALYSIS | ESTHER NAKKAZI | Pertussis, or ...

Dynavax is giving up work on its combination vaccine for tetanus, diphtheria and acellular pertussis (Tdap) after mulling phase 1 data for the shot. | Dynavax is giving up on its combination vaccine ...

Of the vulnerable, not vaccinated or immune respondents, 58% and 62%, respectively, reported not having been offered a ...

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

Market Share: Hep B achieved 44% total U.S. market share in Q3 2024 ... Dynavax Technologies Corp (NASDAQ:DVAX) is actively enrolling in a Phase 12 trial for its shingles vaccine program, with ...